Taken together, these results demonstrated the limitations on immunotherapy associated with PD-L1 which worked with T lymphocytes, and it also raised the possibility of CD47 as a potential therapeutic target for malignant meningioma, since macrophages are significantly enriched in malignant meningioma. Here, CD274 is linked to Anaplastic (Malignant) Meningioma.